Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk. American Journal of Psychiatry. 1994;151(6):945–945.
2.
Davanzo R. Benzodiazepine e allattamento materno. Medico e Bambino. 2008;27:109–14.
3.
Ornoy A, Cohen E. Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. Archives of Disease in Childhood. 1996;75(6):517–20.
4.
Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, et al. Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs. New England Journal of Medicine. 2009;360(16):1597–605.
5.
Zisook S, Burt V. Psychiatric Disorders During Pregnancy. Psychiatric Times. 2003;20(1).
6.
Björnsson E. Hepatotoxicity associated with antiepileptic drugs. Acta Neurologica Scandinavica. 2008;118(5):281–90.
7.
Westergren T, Hjelmeland K, Kristoffersen B, Johannessen SI, Kalikstad B. Probable topiramate-induced diarrhea in a 2-month-old breast-fed child — A case report. Epilepsy & Behavior Case Reports. 2014;2:22–3.
8.
Aydin B, Nayir T, Sahin S, Yildiz A. Olanzapine and Quetiapine Use During Breastfeeding. Journal of Clinical Psychopharmacology. 2015;35(2):206–8.
9.
Ericson A, Källén B, Wiholm BE. Delivery outcome after the use of antidepressants in early pregnancy. European Journal of Clinical Pharmacology. 1999;55(7):503–8.
10.
Chaudron LH, Jefferson JW. Mood Stabilizers During Breastfeeding. The Journal of Clinical Psychiatry. 2000;61(2):79–90.
11.
Imaz ML, Oriolo G, Torra M, Soy D, García-Esteve L, Martin-Santos R. Clozapine Use During Pregnancy and Lactation: A Case-Series Report. Frontiers in Pharmacology. 9.
12.
McAllister-Williams RH, Baldwin DS, Cantwell R, Easter A, Gilvarry E, Glover V, et al. British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017. Journal of Psychopharmacology. 2017;31(5):519–52.
13.
Westin AA, Brekke M, Molden E, Skogvoll E, Castberg I, Spigset O. Treatment With Antipsychotics in Pregnancy: Changes in Drug Disposition. Clinical Pharmacology & Therapeutics. 2018;103(3):477–84.
14.
Gentile S. Antipsychotic Therapy During Early and Late Pregnancy. A Systematic Review. Schizophrenia Bulletin. 2010;36(3):518–44.
15.
Bodén R, Lundgren M, Brandt L, Reutfors J, Kieler H. Antipsychotics During Pregnancy. Archives of General Psychiatry. 2012;69(7).
16.
Collins KO, Comer JB. Maternal haloperidol therapy associated with dyskinesia in a newborn. American Journal of Health-System Pharmacy. 2003;60(21):2253–5.
17.
Habermann F, Fritzsche J, Fuhlbrück F, Wacker E, Allignol A, Weber-Schoendorfer C, et al. Atypical Antipsychotic Drugs and Pregnancy Outcome. Journal of Clinical Psychopharmacology. 2013;33(4):453–62.
18.
Miller LJ. Pharmacotherapy during perinatal period: The Hatherligh Guide to Psychopharmacology. 1999.
19.
Pons G, Rey E, Matheson I. Excretion of Psychoactive Drugs into Breast Milk. Clinical Pharmacokinetics. 1994;27(4):270–89.
20.
Vitale SG, Laganà AS, Muscatello MRA, La Rosa VL, Currò V, Pandolfo G, et al. Psychopharmacotherapy in Pregnancy and Breastfeeding. Obstetrical & Gynecological Survey. 2016;71(12):721–33.
21.
Huybrechts KF, Bateman BT, Desai RJ, Hernandez-Diaz S, Rough K, Mogun H, et al. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study. BMJ. :j3326.
22.
Austin MP, Frilingos M, Lumley J, Hadzi-Pavlovic D, Roncolato W, Acland S, et al. Brief antenatal cognitive behaviour therapy group intervention for the prevention of postnatal depression and anxiety: A randomised controlled trial. Journal of Affective Disorders. 2008;105(1–3):35–44.
23.
Koran LM, Hanna GL, E H. American Psychiatric Association. Practice guideline for the treatment of patients with obsessivecompulsive disorder. Am J Psychiatry. 2007;164(7 Suppl):5–53.
24.
De Schepper S, Vercauteren T, Tersago J, Jacquemyn Y, Raes F, Franck E. Post-Traumatic Stress Disorder after childbirth and the influence of maternity team care during labour and birth: A cohort study. Midwifery. 2016;32:87–92.
25.
Prady SL, Hanlon I, Fraser LK, Mikocka-Walus A. A systematic review of maternal antidepressant use in pregnancy and short- and long-term offspring’s outcomes. Archives of Women’s Mental Health.
26.
Wikner BN, Stiller C, Bergman U, Asker C, Källén B. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiology and Drug Safety. 2007;16(11):1203–10.
27.
Yonkers KA, Gilstad-Hayden K, Forray A, Lipkind HS. Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth Outcomes. JAMA Psychiatry. 2017;74(11):1145.
28.
Krstić D, Pop-Trajković S, M S. The influence of prenatal stress on neurobehavioral development of fetus and child. Acta Facultatis Medicae Naissensis. 2007;24 3 113-20.
29.
Kronenfeld N, Berlin M, Shaniv D, Berkovitch M. Use of Psychotropic Medications in Breastfeeding Women. Birth Defects Research. 2017;109(12):957–97.
30.
Pizarro M, Fontenelle LF, Paravidino DC, Yücel M, Miguel EC, de Menezes GB. An updated review of antidepressants with marked serotonergic effects in obsessive–compulsive disorder. Expert Opinion on Pharmacotherapy. 2014;15(10):1391–401.
31.
Guina J, Merrill B. Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives. Journal of Clinical Medicine. 7(2):17.
32.
Ross LE, Murray BJ, Steiner M. Sleep and perinatal mood disorders: A critical review. J Psychiatry Neurosci. 2005;30(4):247–56.
33.
Laela S, Anna Keliat B, Mustikasari. Thought stopping and supportive therapy can reduce postpartum blues and anxiety parents of premature babies. Enfermería Clínica. 2018;28:126–9.
34.
Nillni YI, Mehralizade A, Mayer L, Milanovic S. Treatment of depression, anxiety, and trauma-related disorders during the perinatal period: A systematic review. Clinical Psychology Review. 2018;66:136–48.
35.
Jarde A, Morais M, Kingston D, Giallo R, MacQueen GM, Giglia L, et al. Neonatal Outcomes in Women With Untreated Antenatal Depression Compared With Women Without Depression. JAMA Psychiatry. 2016;73(8):826.
36.
Cohen LS. Relapse of Major Depression During Pregnancy in Women Who Maintain or Discontinue Antidepressant Treatment. JAMA. 2006;295(5):499.
37.
Mirkin BL. Drug Disposition and Therapy in the Developing Human Being. Pediatric Annals. 1976;5(9):12–42.
38.
Kim DR, Epperson CN, Weiss AR, Wisner KL. Pharmacotherapy of postpartum depression: an update. Expert Opinion on Pharmacotherapy. 2014;15(9):1223–34.
39.
Khan MM. Translational Significance of Selective Estrogen Receptor Modulators in Psychiatric Disorders. International Journal of Endocrinology. 2018;2018:1–12.
40.
Lam RW, Kennedy SH, Parikh SV, MacQueen GM, Milev RV, Ravindran AV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder. The Canadian Journal of Psychiatry. 2016;61(9):506–9.
41.
Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, et al. Antidepressant Drug Effects and Depression Severity. JAMA. 2010;303(1):47.
42.
Morrell CJ, Sutcliffe P, Booth A, Stevens J, Scope A, Stevenson M, et al. A systematic review, evidence synthesis and meta-analysis of quantitative and qualitative studies evaluating the clinical effectiveness, the cost-effectiveness, safety and acceptability of interventions to prevent postnatal depression. Health Technology Assessment. 20(37):1–414.
43.
Damjanović M, Stanković M. Uticaj konstelativnih faktora porodilje na pojavu i karakteristike postpartalne depresije. Acta Medica Medianae. 2007;46–4.
44.
Guille C, Newman R, Fryml LD, Lifton CK, Epperson CN. Management of Postpartum Depression. Journal of Midwifery & Women’s Health. 2013;58(6):643–53.
45.
Miljković S, Stanković M, Lakić A. Psihijatrijski poremećaji tokom trudnoće i postpartalnog perioda. U: Miladinovića P. (ur.): Urgentna stanja u ginekologiji i perinatologiji. Medicinski fakultet u Nišu. 2006;191–227.
46.
Brockington I. Postpartum psychiatric disorders. The Lancet. 2004;363(9405):303–10.
47.
Schapir L, Zalsman M. Bipolar disorder and severe mood dysregulation in children and adolescents. Harefuah. 2008;147:526–31.
48.
Winter S. Gender trouble: The World Health Organization, the International Statistical Classification of Diseases and Related Health Problems (ICD)-11 and the trans kids. Sexual Health. 2017;14(5):423.
49.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 2013.
50.
Kimura Y, Kato T, Miyata H, Sasaki I, Minamino-Muta E, Nagasawa Y, et al. Factors associated with increased levels of brain natriuretic peptide and cardiac troponin I during the peripartum period. PLOS ONE. 14(2):e0211982.
51.
O’Hara MW, Wisner KL. Perinatal mental illness: Definition, description and aetiology. Best Practice & Research Clinical Obstetrics & Gynaecology. 2014;28(1):3–12.
52.
Yoshida K, Smith B, Kumar R. Psychotropic drugs in mothers’ milk: a comprehensive review of assay methods, pharmacokinetics and of safety of breast-feeding. Journal of Psychopharmacology. 1999;13(1):64–80.
53.
Fukushima N, Nanao K, Fukushima H, Namera A, Miura M. A neonatal prolonged QT syndrome due to maternal use of oral tricyclic antidepressants. European Journal of Pediatrics. 2016;175(8):1129–32.
54.
Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, et al. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiology and Drug Safety. 2007;16(10):1086–94.
55.
Hanley GE, Smolina K, Mintzes B, Oberlander TF, Morgan SG. Postpartum Hemorrhage and Use of Serotonin Reuptake Inhibitor Antidepressants in Pregnancy. Obstetrics & Gynecology. 2016;127(3):553–61.
56.
Orsolini L, Bellantuono C. Serotonin reuptake inhibitors and breastfeeding: a systematic review. Human Psychopharmacology: Clinical and Experimental. 2015;30(1):4–20.
57.
poremećaji PVP. Seminar Instituta za mentalno zdravlje. 2003;
58.
Bérard A, Iessa N, Chaabane S, Muanda FT, Boukhris T, Zhao J. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta‐analysis. British Journal of Clinical Pharmacology. 2016;81(4):589–604.
59.
Uguz F. Better Tolerance of Citalopram in a Breastfed Infant Who Could Not Tolerate Sertraline and Paroxetine. Breastfeeding Medicine. 2018;13(1):89–90.
60.
Xu Y, Li Y, Huang X, Chen D, She B, Ma D. Single bolus low-dose of ketamine does not prevent postpartum depression: a randomized, double-blind, placebo-controlled, prospective clinical trial. Archives of Gynecology and Obstetrics. 2017;295(5):1167–74.
61.
Smit M, Dolman KM, Honig A. Mirtazapine in pregnancy and lactation – A systematic review. European Neuropsychopharmacology. 2016;26(1):126–35.
62.
Louik C, Kerr S, Mitchell AA. First-trimester exposure to bupropion and risk of cardiac malformations. Pharmacoepidemiology and Drug Safety. 2014;23(10):1066–75.
63.
Figueroa R. Use of Antidepressants During Pregnancy and Risk of Attention-Deficit/Hyperactivity Disorder in the Offspring. Journal of Developmental & Behavioral Pediatrics. 2010;31(8):641–8.
64.
Hoog SL, Cheng Y, Elpers J, Dowsett SA. Duloxetine and Pregnancy Outcomes: Safety Surveillance Findings. International Journal of Medical Sciences. 2013;10(4):413–9.
65.
Ward HB, Fromson JA, Cooper JJ, De Oliveira G, Almeida M. Recommendations for the use of ECT in pregnancy: literature review and proposed clinical protocol. Archives of Women’s Mental Health. 2018;21(6):715–22.
66.
Rundgren S, Brus O, Båve U, Landén M, Lundberg J, Nordanskog P, et al. Improvement of postpartum depression and psychosis after electroconvulsive therapy: A population-based study with a matched comparison group. Journal of Affective Disorders. 2018;235:258–64.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
